The Mark Foundation for Cancer Research

Drug Discovery Partnership Awards

Last verified:

Details

Funder The Mark Foundation for Cancer Research
TRL 3-6

Eligibility & scope

Accelerates conversion of promising scientific discoveries into cancer therapeutics benefiting patients. Translational/drug-discovery focus. Open to investigators at academic institutions globally. No open deadline specified on page.

More from The Mark Foundation for Cancer Research

Browse all open grants →

Does this grant match your research?

Sign up free to get a personalised match score and weekly alerts for grants like this.

Get started free